Growth-stimulating factor in regenerating canine liver
- PMID: 84151
- PMCID: PMC2978530
- DOI: 10.1016/s0140-6736(79)90519-1
Growth-stimulating factor in regenerating canine liver
Abstract
Extracts from dog livers which had been regenerating for 24, 48, and 72 h after hepatectomy were infused for 6 h into the left portal vein of animals which had fresh portacaval shunts (Eck fistula) and which were killed 2 and 3 days later. The brief exposure to the 48-h and especially the 72-h regenerating liver extracts induced a delayed proliferative response predominantly in the left liver lobes, with a slight spillover effect to the right liver lobes but none to the kidney. The response reached its peak 3 days later. In the left but not the right liver lobes, both the 48-h and the 72-h regenerating liver extract reversed the atrophy ordinarily caused by Eck fistula in 3 days and partly prevented the ultrastructural hepatocyte deterioration characteristic of Eck fistula. The active liver extracts apparently contained a growth-control factor or factors which is (are) not insulin or glucagon.
Similar articles
-
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs.Lancet. 1976 Apr 17;1(7964):821-5. doi: 10.1016/s0140-6736(76)90477-3. Lancet. 1976. PMID: 56646
-
Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regenerating dog liver.Surg Gynecol Obstet. 1980 Oct;151(4):538-44. Surg Gynecol Obstet. 1980. PMID: 6998027 Free PMC article.
-
Intraportal insulin protects from the liver injury of portacaval shunt in dogs.Lancet. 1975 Dec 20;2(7947):1241-2. doi: 10.1016/s0140-6736(75)92076-0. Lancet. 1975. PMID: 53727
-
Screening for candidate hepatic growth factors by selective portal infusion after canine Eck's fistula.Hepatology. 1991 Oct;14(4 Pt 1):665-70. doi: 10.1016/0270-9139(91)90055-z. Hepatology. 1991. PMID: 1916668 Free PMC article.
-
Mechanism of liver regeneration after liver resection and portal vein embolization (ligation) is different?J Hepatobiliary Pancreat Surg. 2009;16(3):292-9. doi: 10.1007/s00534-009-0058-x. Epub 2009 Mar 31. J Hepatobiliary Pancreat Surg. 2009. PMID: 19333540 Review.
Cited by
-
Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure.J Clin Invest. 1988 Feb;81(2):414-9. doi: 10.1172/JCI113334. J Clin Invest. 1988. PMID: 3276728 Free PMC article.
-
Extraction and partial purification of a hepatic stimulatory substance in rats, mice, and dogs.Cancer Res. 1987 Nov 1;47(21):5600-5. Cancer Res. 1987. PMID: 3664466 Free PMC article.
-
Augmenter of liver regeneration (ALR) is a novel biomarker of hepatocellular stress/inflammation: in vitro, in vivo and in silico studies.Mol Med. 2013 Jan 22;18(1):1421-9. doi: 10.2119/molmed.2012.00183. Mol Med. 2013. PMID: 23073658 Free PMC article.
-
The characterization and partial purification of hepatocyte proliferation factor.Ann Surg. 1985 Sep;202(3):296-302. doi: 10.1097/00000658-198509000-00004. Ann Surg. 1985. PMID: 3899028 Free PMC article.
-
Hepatic Regeneration.Viewp Dig Dis. 1979 Sep;11(4):40182. Viewp Dig Dis. 1979. PMID: 21566687 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous